IASLC Launches Beta Version of VIKTOR

IASLC, LCRF Request Proposals for New Research Grant

… Research teams with integrated projects focused on curing … over 4 years. … IASLC, LCRF Request Proposals for New Research Grant … Erin Jungmeyer …

IASLC Announces Partnerships to Spur Oncogene-Driven Lung Cancer Research, Address Global Challenges in Conquering Thoracic Cancers

… The initiatives include a $2.5 million, 4-year research grant and projects to improve lung cancer biomarker … Partnerships to Spur Oncogene-Driven Lung Cancer Research, Address Global Challenges in Conquering Thoracic …

Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture

Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award

Tobacco Control Impacts Everyone in Respiratory Medicine, JTO CRR Editor Says

… In a Q&A with ILCN, new JTO Clinical and Research Reports Editor-in-Chief Dr. Emily Stone discusses her … and the importance of open-access journals in elevating research globally. … Tobacco Control Impacts Everyone in …

In Case You Missed It: IASLC Launches New Education Center

Prof. Caroline Dive Honored with Mary J. Matthews Pathology/Translational Research Award for Work with CTCs

… Honored with Mary J. Matthews Pathology/Translational Research Award for Work with CTCs … Leah Lawrence …

Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors

Program Trains Patient Research Advocates to be STARS

… Program Trains Patient Research Advocates to be STARS … Lauren Evoy Davis …

Journal of Thoracic Oncology’s Impact Factor Rises Again; JTO Clinical and Research Reports Receives First Impact Factor

… Oncology’s Impact Factor Rises Again; JTO Clinical and Research Reports Receives First Impact Factor … Erin Jungmeyer …

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

… with an early-stage non-small-cell lung cancer (NSCLC), research combining prospective and propensity-matched data has … microenvironment and systemic immune responses. 8  Recent research has focused on specific immune cell subsets, such as … with SABR. Substantial clinical and translational research is essential to establish the true effectiveness and …